 Lynn Hassman
Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uveitis | 4 | 2021 | 115 | 1.240 |
Why?
| | Chorioretinitis | 1 | 2024 | 4 | 0.930 |
Why?
| | Papilledema | 1 | 2024 | 40 | 0.880 |
Why?
| | Visual Acuity | 1 | 2024 | 274 | 0.790 |
Why?
| | Retinal Diseases | 1 | 2021 | 76 | 0.740 |
Why?
| | Eye Diseases | 1 | 2021 | 76 | 0.690 |
Why?
| | Metagenome | 1 | 2021 | 122 | 0.690 |
Why?
| | Metagenomics | 1 | 2021 | 131 | 0.680 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2021 | 221 | 0.650 |
Why?
| | Panophthalmitis | 1 | 2018 | 2 | 0.650 |
Why?
| | Eye Infections, Viral | 1 | 2018 | 7 | 0.650 |
Why?
| | Herpes Simplex | 1 | 2018 | 87 | 0.600 |
Why?
| | Vitreous Body | 1 | 2018 | 101 | 0.600 |
Why?
| | Herpesvirus 1, Human | 1 | 2018 | 77 | 0.600 |
Why?
| | Herpesvirus 8, Human | 2 | 2012 | 62 | 0.390 |
Why?
| | Palatine Tonsil | 1 | 2011 | 32 | 0.370 |
Why?
| | Plasma Cells | 1 | 2011 | 57 | 0.360 |
Why?
| | B-Lymphocytes | 1 | 2011 | 772 | 0.260 |
Why?
| | Cell Differentiation | 1 | 2011 | 1700 | 0.220 |
Why?
| | Cell Proliferation | 1 | 2011 | 2191 | 0.220 |
Why?
| | Optic Disk | 1 | 2024 | 38 | 0.220 |
Why?
| | Tomography, Optical Coherence | 1 | 2024 | 130 | 0.210 |
Why?
| | HLA-B Antigens | 1 | 2022 | 56 | 0.210 |
Why?
| | Interferon-gamma | 2 | 2021 | 723 | 0.200 |
Why?
| | Vision, Ocular | 1 | 2021 | 30 | 0.190 |
Why?
| | Scleritis | 1 | 2021 | 18 | 0.190 |
Why?
| | Central Nervous System Diseases | 1 | 2022 | 61 | 0.190 |
Why?
| | Macrophages, Peritoneal | 1 | 2021 | 91 | 0.190 |
Why?
| | Eye Proteins | 1 | 2021 | 71 | 0.180 |
Why?
| | Sarcoidosis | 1 | 2022 | 135 | 0.180 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2022 | 618 | 0.160 |
Why?
| | Gene Expression | 2 | 2021 | 1423 | 0.160 |
Why?
| | Transcriptome | 2 | 2021 | 725 | 0.160 |
Why?
| | Diagnosis, Differential | 2 | 2020 | 1355 | 0.150 |
Why?
| | Precision Medicine | 1 | 2021 | 340 | 0.150 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2021 | 441 | 0.150 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2021 | 288 | 0.150 |
Why?
| | Peptides | 1 | 2022 | 849 | 0.150 |
Why?
| | Autoimmunity | 1 | 2022 | 818 | 0.140 |
Why?
| | Computational Biology | 1 | 2021 | 532 | 0.140 |
Why?
| | Chemokines, CC | 2 | 2006 | 28 | 0.130 |
Why?
| | Humans | 11 | 2024 | 115038 | 0.120 |
Why?
| | MicroRNAs | 1 | 2021 | 603 | 0.120 |
Why?
| | Ultrasonography | 1 | 2018 | 636 | 0.120 |
Why?
| | RNA | 1 | 2021 | 810 | 0.120 |
Why?
| | Macrophages | 1 | 2021 | 1267 | 0.120 |
Why?
| | Algorithms | 1 | 2020 | 1488 | 0.110 |
Why?
| | Gene Expression Regulation | 2 | 2021 | 2329 | 0.110 |
Why?
| | Poly(A)-Binding Protein I | 1 | 2012 | 1 | 0.100 |
Why?
| | RNA, Nuclear | 1 | 2012 | 4 | 0.100 |
Why?
| | Adult | 3 | 2024 | 30654 | 0.100 |
Why?
| | Cytoplasm | 1 | 2012 | 256 | 0.100 |
Why?
| | Aging | 1 | 2021 | 1624 | 0.100 |
Why?
| | Lymphoma, Primary Effusion | 1 | 2011 | 3 | 0.090 |
Why?
| | Castleman Disease | 1 | 2011 | 13 | 0.090 |
Why?
| | Disease Transmission, Infectious | 1 | 2011 | 56 | 0.090 |
Why?
| | RNA, Messenger | 2 | 2021 | 2563 | 0.090 |
Why?
| | Viral Proteins | 1 | 2012 | 281 | 0.090 |
Why?
| | Genome, Viral | 1 | 2011 | 119 | 0.090 |
Why?
| | Antigens, Viral | 1 | 2011 | 176 | 0.090 |
Why?
| | Cell Nucleus | 1 | 2012 | 556 | 0.080 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 2341 | 0.080 |
Why?
| | RNA, Viral | 1 | 2012 | 567 | 0.080 |
Why?
| | Young Adult | 1 | 2024 | 10498 | 0.080 |
Why?
| | Female | 4 | 2024 | 59610 | 0.080 |
Why?
| | Retrospective Studies | 1 | 2024 | 12547 | 0.070 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2022 | 691 | 0.070 |
Why?
| | Receptors, Chemokine | 1 | 2006 | 43 | 0.070 |
Why?
| | Middle Aged | 2 | 2024 | 26826 | 0.070 |
Why?
| | Nuclear Proteins | 1 | 2011 | 593 | 0.070 |
Why?
| | Bronchial Hyperreactivity | 1 | 2006 | 95 | 0.070 |
Why?
| | Aged | 1 | 2024 | 19119 | 0.060 |
Why?
| | Adolescent | 1 | 2024 | 17862 | 0.060 |
Why?
| | Interleukin-13 | 1 | 2006 | 123 | 0.060 |
Why?
| | Chemokines, CXC | 1 | 2004 | 58 | 0.060 |
Why?
| | Eosinophils | 1 | 2006 | 281 | 0.060 |
Why?
| | Cells, Cultured | 1 | 2011 | 3896 | 0.050 |
Why?
| | Uveitis, Anterior | 1 | 2022 | 11 | 0.050 |
Why?
| | Lung | 2 | 2006 | 3595 | 0.050 |
Why?
| | Synovial Fluid | 1 | 2022 | 57 | 0.050 |
Why?
| | Cross Reactions | 1 | 2022 | 117 | 0.050 |
Why?
| | Mice, Knockout | 3 | 2021 | 2585 | 0.050 |
Why?
| | Peptide Library | 1 | 2022 | 81 | 0.050 |
Why?
| | Amino Acid Motifs | 1 | 2022 | 198 | 0.050 |
Why?
| | Trans-Activators | 1 | 2004 | 368 | 0.050 |
Why?
| | Spondylitis, Ankylosing | 1 | 2022 | 43 | 0.050 |
Why?
| | Gene Expression Profiling | 3 | 2021 | 1523 | 0.050 |
Why?
| | Thioglycolates | 1 | 2021 | 3 | 0.050 |
Why?
| | Male | 2 | 2024 | 55729 | 0.050 |
Why?
| | Macrophage Activation | 1 | 2021 | 164 | 0.040 |
Why?
| | Cellular Senescence | 1 | 2021 | 153 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2006 | 1317 | 0.040 |
Why?
| | Chronic Disease | 2 | 2021 | 1591 | 0.040 |
Why?
| | Animals | 5 | 2021 | 31867 | 0.040 |
Why?
| | Autoantigens | 1 | 2022 | 397 | 0.040 |
Why?
| | Genetic Markers | 1 | 2021 | 323 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2021 | 186 | 0.040 |
Why?
| | Lung Diseases | 1 | 2006 | 703 | 0.040 |
Why?
| | Gene Regulatory Networks | 1 | 2021 | 229 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 387 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2004 | 1318 | 0.040 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2022 | 965 | 0.030 |
Why?
| | Mitochondria | 1 | 2021 | 750 | 0.030 |
Why?
| | Mice | 4 | 2021 | 14927 | 0.030 |
Why?
| | Inflammation | 2 | 2021 | 2485 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2020 | 3015 | 0.030 |
Why?
| | Subcellular Fractions | 1 | 2012 | 78 | 0.030 |
Why?
| | Allergens | 2 | 2006 | 417 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2021 | 4718 | 0.030 |
Why?
| | Asthma | 1 | 2004 | 2051 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2012 | 292 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2012 | 396 | 0.020 |
Why?
| | Herpesviridae Infections | 1 | 2012 | 138 | 0.020 |
Why?
| | RNA, Untranslated | 1 | 2012 | 113 | 0.020 |
Why?
| | Protein Transport | 1 | 2012 | 398 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 3419 | 0.020 |
Why?
| | Virus Replication | 1 | 2012 | 393 | 0.020 |
Why?
| | Cytokines | 2 | 2006 | 1843 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2012 | 1084 | 0.020 |
Why?
| | Receptors, CCR3 | 1 | 2006 | 8 | 0.020 |
Why?
| | Chemokine CCL11 | 1 | 2006 | 22 | 0.020 |
Why?
| | Mucus | 1 | 2006 | 54 | 0.020 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2006 | 55 | 0.020 |
Why?
| | Cathepsins | 1 | 2006 | 22 | 0.020 |
Why?
| | Receptors, Cytokine | 1 | 2006 | 33 | 0.020 |
Why?
| | Disease Models, Animal | 2 | 2006 | 3545 | 0.020 |
Why?
| | Doxycycline | 1 | 2006 | 55 | 0.020 |
Why?
| | Mast Cells | 1 | 2006 | 117 | 0.020 |
Why?
| | STAT6 Transcription Factor | 1 | 2004 | 22 | 0.020 |
Why?
| | Chemokine CXCL9 | 1 | 2004 | 21 | 0.020 |
Why?
| | Chemokine CXCL10 | 1 | 2004 | 34 | 0.020 |
Why?
| | Ligands | 1 | 2006 | 565 | 0.010 |
Why?
| | STAT1 Transcription Factor | 1 | 2004 | 64 | 0.010 |
Why?
| | Ovalbumin | 1 | 2004 | 162 | 0.010 |
Why?
| | Eosinophilia | 1 | 2006 | 186 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2006 | 744 | 0.010 |
Why?
| | Cell Movement | 1 | 2006 | 866 | 0.010 |
Why?
| | Down-Regulation | 1 | 2004 | 599 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2004 | 1153 | 0.010 |
Why?
| | Up-Regulation | 1 | 2004 | 812 | 0.010 |
Why?
| | Kinetics | 1 | 2004 | 1558 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2006 | 1955 | 0.010 |
Why?
| | Signal Transduction | 1 | 2004 | 4525 | 0.010 |
Why?
|
|
Hassman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|